ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Significant Increase in Moderate to High KDPI Kidney Transplants Using a Multi-Operational Approach: Results from the COIIN (Collaborative Innovation and Improvement Network) Initiative

    T. Pesavento1, J. Foutz2, K. Sisaithong2, D. Klassen2, L. Stillion1, A. Rajab1, R. Pelletier3, K. Washburn1, H. Tosoc-Haskell2

    1Ohio State University, Columbus, OH, 2UNOS, Richmond, VA, 3Robert Wood Johnson, New Brunswick, NJ

    *Purpose: Kidney transplant (KTx) utilization of moderate to high KDPI (MH-KDPI) deceased donor kidneys remains an opportunity to reduce organ discards. We participated in COIIN,…
  • 2019 American Transplant Congress

    Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study

    B. Nashan1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, F. Braun1

    1Study Group, Hephaistos, Germany, 2Novartis Pharma GmbH, Nuernberg, Germany

    *Purpose: The HEPHAISTOS study was set up to compare early use of everolimus [EVR] combined with reduced tacrolimus [rTAC] versus standard-dose tacrolimus [TAC-C) in de…
  • 2019 American Transplant Congress

    Circulating T Follicular Helper Proliferation And Memory B Cell Activation Correlate With Donor Specific Allo-antibody Occurrence And Antibody-mediated Rejection After Kidney Transplantation

    K. Louis1, C. Macedo1, M. Marrari1, B. Ramaswami1, M. Lucas1, B. Elinoff1, M. Yamada1, X. Gu1, G. Chalasani1, A. Zeevi1, P. Randhawa1, C. Lefaucheur2, D. Metes1

    1Surgery, University of Pittsburgh, Pittsburgh, PA, 2Inserm Unité mixte de recherche 1160, Paris, France

    *Purpose: Crosstalk between T follicular helper (Tfh) cells and B cells is necessary for class-switched antibody generation. The contribution of memory Tfh and B cells…
  • 2019 American Transplant Congress

    Ligation Of Hla Class Il Molecules Disrupts Endothelial Barrier Through Src-dependent Ve-cadherin Destabilization

    F. Li1, R. A. Sosa1, N. M. Valenzuela1, E. Rozengurt2, E. F. Reed1

    1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, 2Digestive Diseases Research Center, University of California, Los Angeles, Los Angeles, CA

    *Purpose: Microvascular inflammation, vascular permeability, and accumulation of intravascular mononuclear cells are characteristics of acute and chronic antibody-mediated rejection. Vascular endothelial cadherin (VE-Cadherin) is a…
  • 2019 American Transplant Congress

    Incidence and Risk of Allograft Rejection after Cardiac Transplantation in Left Ventricular Assist Device Patients

    R. C. Patel1, L. B. Cooper2, S. D. Barnett2, R. T. Cole2, M. A. Psotka2, A. Cochrane2, S. Sinha2, L. J. Bogar2, S. S. Desai2, P. Shah2

    1Virginia Commonwealth University School of Medicine, Inova Fairfax Hospital, Falls Church, VA, 2Department of Heart Failure and Transplant, Inova Heart and Vascular Institute, Falls Church, VA

    *Purpose: Left ventricular assist devices (LVAD) are made of biomaterials that have been shown to cause allosensitization. Single center studies have suggested that patients bridged…
  • 2019 American Transplant Congress

    Early Steroid Withdrawal in African American Deceased Donor Renal Transplant Recipients with Alemtuzumab Induction: Is Graft Loss on the Horizon?

    R. Lynn, B. Ravichandran, T. Sparkes, A. Haririan, J. Bromberg, J. Casale

    University of Maryland Medical Center, Baltimore, MD

    *Purpose: The safety of early steroid withdrawal (ESW) in African American (AA) deceased donor renal transplant recipients (DDRTs) is unclear. This study assessed the impact…
  • 2019 American Transplant Congress

    The Evolution of Body Mass Index after Kidney Transplantation in Recipients with a Previous Laparoscopic Sleeve Gastrectomy

    G. Chan, F. Briere

    Universite de Montreal, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada

    *Purpose: Bariatric surgery is one of the most common operations. Laparoscopic sleeve gastrectomy (LSG) has been reported to prepare candidates for listing. However, weight gain…
  • 2019 American Transplant Congress

    Transplant Center Practices Are the Primary Drivers of United States Donation after Circulatory Death Liver Transplantation

    L. Beal1, D. T. Nguyen2, T. Menser3, S. Zajac1, E. A. Graviss2, M. J. Hobeika1

    1Department of Surgery, Houston Methodist Hospital, Houston, TX, 2Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, 3Center for Outcomes Research, Houston Methodist Research Institute, Houston, TX

    *Purpose: We hypothesize that a few high-utilization donation after circulatory death (DCD) liver centers are the primary drivers of the dissimilar rates of DCD liver…
  • 2019 American Transplant Congress

    Role of MHC Class II in B Cell and Regulatory T Cell Development

    S. K. Germana, Z. Wang, C. A. Huang, L. Kojima, C. G. Rickert, J. F. Markmann, C. LeGuern

    Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA

    *Purpose: Therapies involving CD4 regulatory T cells (Tregs) are promising approaches to mitigate graft rejection and autoimmunity. Understanding of the activation mechanisms that initiate Treg…
  • 2019 American Transplant Congress

    B Cell-Specific IRE1a Deficiency Protects Renal Allografts from Rejection via Inhibition of Donor-Specific Antibodies and Induction of B Regulatory Cells

    L. Qiu1, J. Wang1, X. Yeap1, D. Fang2, Z. J. Zhang1

    1Comprehensive Transplant Center, Department of Surgery, Northwestern University, Chicago, IL, 2Department of Pathology, Northwestern University, Chicago, IL

    *Purpose: Despite the progress in immunosuppressive regimens, antibody-mediated rejection remains a major contributor to renal allograft loss in recipients with donor-specific antibodies (DSA). IRE1a, an…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences